Clinical Trial Update: Characterization of Immunological Profile of Renal Transplant Patients Undergoing Induction Treatment With Thymoglobulin vs. IL-2 Receptor Antagonist Basiliximab

View source ↗

Summary

A completed trial characterizes the immunological profiles of renal transplant patients undergoing induction therapy with thymoglobulin compared to Basiliximab …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Transplantation

Drugs mentioned

• Basiliximab (basiliximab)
• Thymoglobulin (rabbit anti-thymocyte globulin)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Renal Transplantation | Status: COMPLETED